SKI Market

Indian Indices

Sensex

81,228.09 -1,041.69
( -1.27%)

Global Indices

Nasdaq

48,928.31 -164.26
(-0.33%)

Dow Jones

6,963.16 -26.85
(-0.38%)

Hang Seng

53,392.10 16.50
(0.03%)

Nikkei 225

10,214.90 43.14
(0.42%)

Forex

USD-INR

91.92 0.08
(0.09%)

EUR-INR

109.97 0.03
(0.03%)

GBP-INR

126.94 0.27
(0.21%)

JPY-INR

0.60 0.00
(0.00%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

91669

INE0PLZ01012

37.7171887

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNREST

7.08

14.16

EPS(TTM)

Face Value()

Div & Yield %

4.66

Back

Fynx Capital reports standalone net loss of Rs 0.82 crore in the December 2025 quarter

Jan 29,2026

Net Loss of Fynx Capital reported to Rs 0.82 crore in the quarter ended December 2025 as against net loss of Rs 0.45 crore during the previous quarter ended December 2024. Sales reported to Rs 1.47 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1.47	0	0
OPM %	-42.18	0	-
PBDT	-0.82	-0.36	-128
PBT	-0.89	-0.45	-98
NP	-0.82	-0.45	-82

81,228.09 -1,041.69 ( -1.27%)

48,928.31 -164.26 (-0.33%)

6,963.16 -26.85 (-0.38%)

53,392.10 16.50 (0.03%)

10,214.90 43.14 (0.42%)

91.92 0.08 (0.09%)

109.97 0.03 (0.03%)

126.94 0.27 (0.21%)

0.60 0.00 (0.00%)